Your browser doesn't support javascript.
loading
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study.
McDade, Eric; Cummings, Jeffrey L; Dhadda, Shobha; Swanson, Chad J; Reyderman, Larisa; Kanekiyo, Michio; Koyama, Akihiko; Irizarry, Michael; Kramer, Lynn D; Bateman, Randall J.
Affiliation
  • McDade E; The DIAN-TU, Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
  • Cummings JL; Chambers-Grundy Center for Transformative Neuroscience, Quirk Brain Health and Biomarker Laboratory, Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA.
  • Dhadda S; Eisai Inc., Nutley, NJ, USA.
  • Swanson CJ; Eisai Inc., Nutley, NJ, USA.
  • Reyderman L; Eisai Inc., Nutley, NJ, USA.
  • Kanekiyo M; Eisai Inc., Nutley, NJ, USA.
  • Koyama A; Eisai Inc., Nutley, NJ, USA.
  • Irizarry M; Eisai Inc., Nutley, NJ, USA.
  • Kramer LD; Eisai Inc., Nutley, NJ, USA.
  • Bateman RJ; The DIAN-TU, Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA. batemanr@wustl.edu.
Alzheimers Res Ther ; 14(1): 191, 2022 12 21.
Article in En | MEDLINE | ID: mdl-36544184
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease Type of study: Clinical_trials Limits: Humans Language: En Journal: Alzheimers Res Ther Year: 2022 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease Type of study: Clinical_trials Limits: Humans Language: En Journal: Alzheimers Res Ther Year: 2022 Document type: Article Affiliation country: United States